In February 2026, The Wall Street Transcript published an exclusive interview with CytoMed Therapeutics Ltd (NASDAQ: GDTC) Chairman Choo Chee Kong. The interview covered the company’s... Read More
rising
ReportLinker A new generation of POC devices that will change gastrointestinal diagnostic routes has been made possible by recent improvements in analytical methods. Hence, Gastrointestinal... Read More

CytoMed Therapeutics Ltd — A Rising Star in Singapore’s Cancer Biotechnology Sector